Lazard Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
|
|||||
|
2025
Q1 | $639K | Sell |
|
|||||
|
2024
Q4 | $1.99M | Buy |
|
|||||
|
2024
Q3 | $1.49M | Sell |
|
|||||
|
2024
Q2 | $7.24M | Sell |
|
|||||
|
2024
Q1 | $17.7M | Buy |
|
|||||
|
2023
Q4 | $12.8M | Buy |
|
|||||
|
2023
Q3 | $10.2M | Buy |
|
|||||
|
2023
Q2 | $3.81M | Buy |
|
|||||
|
2023
Q1 | $3.08M | Buy |
|
|||||
|
2022
Q4 | $3.22M | Buy |
|
|||||
|
2022
Q3 | $2.76M | Buy |
|
|||||
|
2022
Q2 | $2.15M | Buy |
|
|||||
|
2022
Q1 | $1K | Buy |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $11.3M | Sell |
|
|||||
|
2021
Q2 | $47.4M | Sell |
|
|||||
|
2021
Q1 | $38.1M | Sell |
|
|||||
|
2020
Q4 | $39.1M | Sell |
|
|||||
|
2020
Q3 | $37.9M | Sell |
|
|||||
|
2020
Q2 | $36.1M | Buy |
|
|||||
|
2020
Q1 | $23.5M | Buy |
|
|||||
|
2019
Q4 | $27.5M | Buy |
|
|||||
|
2019
Q3 | $18M | Buy |
|
|||||
|
2019
Q2 | $6.47M | Buy |
|
|||||
|
2019
Q1 | $6.41M | Buy |
|
|||||
|
2018
Q4 | $447K | Buy |
|
|||||
|
2018
Q3 | $175K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $221K | Buy |
|
|||||
|
2015
Q3 | $149K | Sell |
|
|||||
|
2015
Q2 | $211K | Buy |
|